The present disclosure relates generally to medical devices for sealing tissue, and, more particularly, to an electrosurgical device in the form of forceps including an end effector assembly including opposing jaws for providing controlled compression and energy emission for sealing, cauterizing, coagulating, and/or desiccating vessels and vascular tissue including been previously sutured or stapled.
Most surgical procedures require some form of closure of a vessel, wound, or incision. For example, in many procedures, a surgeon will rely on sutures as a means of surgically occluding a vessel, closing wounds, as well as coupling portions of tissue to one another (e.g., bypass surgeries and anastomoses formation). More recently, surgical staples and clips have become commonly used in place of sutures, where appropriate, as stapling can be much faster than suturing by hand, and can also be more accurate and consistent. Furthermore, stapling may not require the degree of experience and expertise that suturing generally requires. Staples may primarily be used in bowel and lung surgery, because staple lines may be more consistent and therefore less likely to leak blood, air or bowel contents.
While the use of staples for thoracic surgery has been widely accepted and regarded as a safe procedure, there are instances in which stapling is may be insufficient and unable to achieve complete closure of a wound, incision, or vessel. This may be particularly critical in certain thoracic procedures, particularly those involving pulmonary vasculature where the leakage of air and/or fluid contents can be life threatening.
In some procedures, a surgeon may rely on an electrosurgical device to seal or cauterize a vessel, wound, or incision by applying energy (e.g., electrical current, radiofrequency (RF), thermal energy, etc.) to the target tissue or vessel. Some current devices, particularly electrosurgical forceps, use mechanical action between opposing jaws to constrict tissue and further apply electrical energy to effect hemostasis by heating the tissue and blood vessels to coagulate, cauterize, cut and/or seal tissue. While current electrosurgical forceps allow for the sealing of tissue or vessels, such devices have shortcomings and are unable to be used in conjunction with sutures and/or staples. For example, some sutures and staples may be fragile (e.g., formed from bioabsorbable materials) and thus may be unable to withstand the compression forces and/or energy delivered via current electrosurgical forceps. Thus, the use of current electrosurgical forceps on a vessel or wound that includes a suture or staple may result in damage to the suture or staple, which may compromise the integrity of the seal and may further result in serious complications, such as an increase in wound severity as well as life-threating infection.
An electrosurgical device can be delivered to a surgical site to provide sealing of vessels and/or vascular tissue. The device is useful for supplementing an initial closure of a vessel, wound, or incision via suturing or stapling. In particular, the device is configured to apply controlled compression and energy emission to the vessel, wound, or incision while maintaining the integrity of the suture or staple (i.e., without damaging the suture or staple). Accordingly, the electrosurgical device of the present disclosure provides for complete closure, thereby preventing leakage of air, contents, or fluid and subsequently preventing infection or life threatening complications.
The electrosurgical device is generally in the form of forceps and includes a probe acting as a handle and an end effector assembly positioned at a distal end of the probe. The end effector assembly includes opposing jaws configured to move relative to one another between open and closed positions upon corresponding input from the surgeon (i.e., via control from a trigger on the probe). Each jaw includes a deformable pad or cushion including an electrode array positioned along an exterior surface thereof and is configured to provide controlled compression upon a target tissue or vessel and subsequent delivery of radiofrequency (RF) energy for effectively sealing, cauterizing, coagulating, and/or desiccating the target tissue or vessel while maintaining the integrity of any suture(s) or staple(s).
In particular, the deformable cushion may generally include a nonconductive material that is flexible and configured to transition from a default shape (e.g., generally planar contact surface) to a deformed shape (e.g., one or more portions of contact surface become compressed) upon contact with a vessel or tissue and corresponding suture(s) or staple(s). The compression of the cushion allows for the electrode array to better conform to the contour of the target tissue or vessel on either side of a suture or staple, thereby improving contact and ablation/coagulation performance and enabling effective sealing around the suture or staple.
The electrode array on each cushion is configured to emit a non-ionizing radiation, such as RF energy, in a bipolar configuration for sealing, cauterizing, coagulating, and/or desiccating the vessel or tissue. The electrode array is composed of one or more conductive members (e.g., conductive wires) positioned along a length of the exterior surface of the cushion. In some embodiments, each of the plurality of conductive wires, or one or more sets of a combination of conductive wires, may be configured to independently receive an electrical current from an energy source (e.g., RF generator) and independently conduct energy, the energy including RF energy. This allows energy to be selectively delivered to a designated conductive wire or combination of conductive wires. This design also enables the ablation device to function in a bipolar mode because a first conductive wire (or combination of conductive wires) can deliver energy to the surrounding tissue through its electrical connection with an ablation generator while a second conductive wire (or combination of conductive wiress) can function as a ground or neutral conductive member.
The electrosurgical device is configured to deliver the RF energy via a virtual electrode arrangement, which includes distribution of a fluid along the exterior surface of each cushion and, upon activation of the electrode array, the fluid may carry, or otherwise promote, energy emitted from the electrode array to the surrounding tissue. In particular, each cushion includes one or more perforations in fluid communication with at least one lumen of the probe shaft configured receive a fluid, such as saline, from a fluid source. The one or more perforations allow the passage of the fluid to the exterior surface of the cushion. Upon transitioning the opposing jaws to the closed position, the corresponding cushions engage opposing sides of the target tissue or vessel, including one or more sutures or staples. The surgeon can apply force so as to compress the target tissue or vessel between the opposing cushions, wherein the exterior surface of each cushion generally conforms to the surface of the tissue or vessel and the suture(s) or staple(s) while maintaining the integrity of the suture or staple (i.e., without damaging the suture or staple). Due to the conforming nature of the cushions, each electrode array is able to come into contact with, and effectively seal, portions of the target tissue or vessel that are immediately adjacent to the suture(s) or staple(s), which are generally missed with current electrosurgical forceps.
The surgeon may then activate both the fluid delivery and eletrode array, each of which can be independently controlled via a controller. The fluid weeping through the perforations to the outer surface of the cushions is able to carry energy from electrode array, thereby creating a virtual electrode. Upon the fluid weeping through the perforations, a pool or thin film of fluid is formed on the exterior surface of the cushions and is configured to seal portions of the target tissue of vessel in contact therewith via the RF energy carried from the electrode array. Accordingly, the electrosurgical device of the present disclosure provides for complete closure of the target tissue or vessel, thereby preventing or reducing the risk of leakage of air, contents, or fluid and subsequently preventing infection or life threatening complications that may otherwise occur with simply a suture or staple closure.
The electrosurgical device of the present disclosure provides numerous advantages. In particular, the electrosurgical device is useful for supplementing an initial closure of a vessel, wound, or incision via suturing or stapling. The deformable cushion on each opposing jaw is configured to deform upon being compressed against the target tissue or vessel and the suture(s) or staple(s) such that the exterior surface of each cushion conforms and corresponds to the tissue or vessel surface and suture(s) or staple(s). The cushion is able to be compressed against the suture or staple without causing physical damage thereto or compromising the structural integrity of the suture or staple. Furthermore, due to the conforming nature of the cushions, each electrode array is able to come into contact with, and effectively seal, portions of the target tissue or vessel that are immediately adjacent to the suture(s) or staple(s), which are generally missed with current electrosurgical forceps as a result of the rigid, non-compliant sealing plates of such forceps. The virtual electrode arrangement of the present device further allows for a non-sticking surface during a sealing procedure, as the saline generally acts as a buffer between the tissue surface and the surface of the conductive wires. Furthermore, the virtual electrode provides for controlled emission of energy, including at least length of elapsed time and intensity, which, in turn, effectively controls the thermal energy released for sealing, which can be consistently maintained between 60° C. and 100° C. to prevent inadvertent damage to surrounding tissue.
Features and advantages of the claimed subject matter will be apparent from the following detailed description of embodiments consistent therewith, which description should be considered with reference to the accompanying drawings, wherein:
For a thorough understanding of the present disclosure, reference should be made to the following detailed description, including the appended claims, in connection with the above-described drawings. Although the present disclosure is described in connection with exemplary embodiments, the disclosure is not intended to be limited to the specific forms set forth herein. It is understood that various omissions and substitutions of equivalents are contemplated as circumstances may suggest or render expedient.
By way of overview, the present disclosure is generally directed to an electrosurgical device can be delivered to a surgical site to provide sealing of vessels and/or vascular tissue. The device is useful for supplementing an initial closure of a vessel, wound, or incision via suturing or stapling. In particular, the device is configured to apply controlled compression and energy emission to the vessel, wound, or incision while maintaining the integrity of the suture or staple (i.e., without damaging the suture or staple). Accordingly, the electrosurgical device of the present disclosure provides for complete closure, thereby preventing leakage of air, contents, or fluid and subsequently preventing infection or life threatening complications.
The electrosurgical device is generally in the form of forceps and includes a probe acting as a handle and an end effector assembly positioned at a distal end of the probe. The end effector assembly includes opposing jaws configured to move relative to one another between open and closed positions upon corresponding input from the surgeon (i.e., via control from a trigger on the probe). Each jaw includes a deformable pad or cushion including an electrode array positioned along an exterior surface thereof and is configured to provide controlled compression upon a target tissue or vessel and subsequent delivery of radiofrequency (RF) energy for effectively sealing, cauterizing, coagulating, and/or desiccating the target tissue or vessel while maintaining the integrity of any suture(s) or staple(s). The electrosurgical device is configured to deliver radiofrequency (RF) energy via a virtual electrode arrangement, which includes distribution of a fluid along the exterior surface of each cushion and, upon activation of the electrode array, the fluid may carry, or otherwise promote, energy emitted from the electrode array to the surrounding tissue. In particular, each cushion includes one or more perforations in fluid communication with at least one lumen of the probe shaft configured receive a fluid, such as saline, from a fluid source. The one or more perforations allow the passage of the fluid to the exterior surface of the cushion. Upon transitioning the opposing jaws to the closed position, the corresponding cushions engage opposing sides of the target tissue or vessel, including one or more sutures or staples. The surgeon can apply force so as to compress the target tissue or vessel between the opposing cushions, wherein the exterior surface of each cushion generally conforms to the surface of the tissue or vessel and the suture(s) or staple(s) while maintaining the integrity of the suture or staple (i.e., without damaging the suture or staple). Due to the conforming nature of the cushions, each electrode array is able to come into contact with, and effectively seal, portions of the target tissue or vessel that are immediately adjacent to the suture(s) or staple(s), which are generally missed with current electrosurgical forceps.
The surgeon may then activate both the fluid delivery and eletrode array, each of which can be independently controlled via a controller. The fluid weeping through the perforations to the outer surface of the cushions is able to carry energy from electrode array, thereby creating a virtual electrode. Upon the fluid weeping through the perforations, a pool or thin film of fluid is formed on the exterior surface of the cushions and is configured to seal portions of the target tissue or vessel in contact therewith via the RF energy carried from the electrode array. Accordingly, the electrosurgical device of the present disclosure provides for complete closure of the target tissue or vessel, thereby preventing or reducing the risk of leakage of air, contents, or fluid and subsequently preventing infection or life threatening complications that may otherwise occur with simply a suture or staple closure.
The device controller 18 may include hardware/software configured to provide a user with the ability to control electrical output to the electrosurgical device 14 in a manner so as to control energy output to a tissue or vessel intended to be sealed or that has initially undergone suturing or stapling. For example, as will be described in greater detail herein, the electrosurgical device may be configured to operate at least in a “bipolar mode” based on input from a user (e.g., surgeon, clinician, etc.) resulting in the emission of radiofrequency (RF) energy in a bipolar configuration. In some embodiments, the device 14 may be configured to operate in other modes, such as a “measurement mode”, in which data can be collected, such as certain measurements (e.g., temperature, conductivity (impedance), etc.) that can be taken and further used by the controller 18 so as to provide an estimation of the state of tissue during a sealing procedure, as will be described in greater detail herein. In some embodiments, the device controller 18 may be housed within the electrosurgical device 14. The RF generator 20 may also be connected to a separate return electrode 15 that is attached to the skin of the patient 12.
As will be described in greater detail herein, during a sealing procedure, the generator 20 may generally provide RF energy (e.g., electrical energy in the radiofrequency (RF) range (e.g., 350-800 kHz)) to an electrode array of the electro surgical device 14, as controlled by the device controller 18. At the same time, saline may also be provided to and released from the end effector assembly 16. In some embodiments, the RF energy travels through the blood and tissue of the patient 12 to a return electrode and, in the process, provides energy emission (e.g., sealing, cauterizing, coagulating and/or desiccating) to tissue adjacent to portions of the electrode array that have been activated.
In some examples, the electrosurgical device 14 may further include a user interface (not shown) serving as the device controller 18 and in electrical communication with at least one of the generator 20, the irrigation pump 22, and the electrosurgical device 14. The user interface may include, for example, selectable buttons for providing an operator with one or more operating modes with respect to controlling the energy emission output of the device 14, as will be described in greater detail herein. For example, selectable buttons may allow a user to control electrical output to the electrosurgical device 14 in a manner so as to control the sealing, cauterizing, coagulating, and/or desiccating of portions of a tissue or vessel. Furthermore, in some embodiments, selectable buttons may provide an operator to control the delivery of fluid from the irrigation pump 22. vvAs shown, the end effector assembly 16 includes first and second jaws 38a, 38b generally opposing one another and configured to move relative to one another in response to user interaction with the trigger 40, as will be described in greater detail herein.
In particular, the deformable cushion may generally include a nonconductive material that is flexible and configured to transition from a default shape (e.g., generally planar contact surface) to a deformed shape (e.g., one or more portions of contact surface become compressed) upon contact with a vessel or tissue and corresponding sutures or staples (see
Since each conductive wire 46 in the electrode array 44 may be electrically independent, each conductive wire 46 can be connected in a fashion that allows for impedance measurements using bipolar impedance measurement circuits. For example, the conductive wires can be configured in such a fashion that tetrapolar or guarded tetrapolar electrode configurations can be used. For instance, one pair of conductive wires could function as the current driver and the current return, while another pair of conductive wires could function as a voltage measurement pair. Accordingly, a dispersive ground pad can function as current return and voltage references.
The electrosurgical device 14 is configured to deliver the RF energy via a virtual electrode arrangement, which includes distribution of a fluid along the exterior surface of each cushion 42 and, upon activation of the electrode array 44, the fluid may carry, or otherwise promote, energy emitted from the electrode array 44 to the surrounding tissue. In particular, each cushion 42 includes one or more perforations 48 in fluid communication with at least one lumen of the probe shaft configured receive a fluid, such as saline, from a fluid source (e.g., the irrigation drip 22). The one or more perforations 48 allow the passage of the fluid to the exterior surface of the cushion 42. As shown, each of the perforations 48 are generally aligned with an associated conductive wire 46. Accordingly, upon fluid weeping through the perforations 48, a pool or thin film of fluid is formed on the exterior surface of the cushion 42 and configured to ablate and/or coagulate via the electrical current conducted by the one or more conductive wires 46 of the electrode array 44, as described in greater detail herein.
As shown, once a surgeon positions the end effector assembly 16 relative to a target tissue to be sealed, the surgeon may then close the jaws 38a, 38b so as to clamp the target tissue there between. Upon transitioning the opposing jaws 38a, 38b to the closed position, the corresponding cushions 42a, 42b engage opposing sides of the target tissue, including one or more sutures or staples. The surgeon can apply force so as to compress the target tissue between the opposing cushions 38a, 38b, wherein the exterior surface of each cushion 42a, 42b generally conforms to the surface of the tissue and the staple while maintaining the integrity of the staple (i.e., without damaging the staple). Due to the conforming nature of the cushions 38a, 38b, each electrode array 44, specifically the conductive wires 46 is able to come into close contact with, and effectively seal, portions of the target tissue that are immediately adjacent to the staple, which are generally missed with current electrosurgical forceps. As shown, the end effector assembly 16 can generally accommodate an entire cross section of the lung tissue (lobe) to be received between the opposing jaws 38a, 38b.
The surgeon may then activate both the fluid delivery and electrode array 44, each of which can be independently controlled via controller 18, as previously described. The fluid weeping through the perforations 48, to the outer surface of the cushions 42a, 42b is able to carry energy from electrode array 44, thereby creating a virtual electrode. Upon the fluid weeping through the perforations 48, a pool or thin film of fluid is formed on the exterior surface of the cushions 38a, 38b and is configured to seal portions of the target tissue in contact therewith via the RF energy carried from the electrode array 44. Accordingly, the electrosurgical device 14 of the present disclosure provides for complete closure of the target tissue, thereby preventing or reducing the risk of leakage of air, contents, or fluid and subsequently preventing infection or life threatening complications that may otherwise occur with simply a suture or staple closure.
The electrosurgical device of the present disclosure provides numerous advantages. In particular, the electrosurgical device is useful for supplementing an initial closure of a vessel, wound, or incision via suturing or stapling. The deformable cushion on each opposing jaw is configured to deform upon being compressed against the target tissue or vessel and the suture(s) or staple(s) such that the exterior surface of each cushion conforms and corresponds to the tissue or vessel surface and suture(s) or staple(s). The cushion is able to be compressed against the suture or staple without causing physical damage thereto or compromising the structural integrity of the suture or staple. Furthermore, due to the conforming nature of the cushions, each electrode array is able to come into contact with, and effectively seal, portions of the target tissue or vessel that are immediately adjacent to the suture(s) or staple(s), which are generally missed with current electrosurgical forceps as a result of the rigid, non-compliant sealing plates of such forceps. The virtual electrode arrangement of the present device further allows for a non-sticking surface during a sealing procedure, as the saline generally acts as a buffer between the tissue surface and the surface of the conductive wires. Furthermore, the virtual electrode provides for controlled emission of energy, including at least length of elapsed time and intensity, which, in turn, effectively controls the thermal energy released for sealing, which can be consistently maintained between 60° C. and 100° C. to prevent inadvertent damage to surrounding tissue.
Reference throughout this specification to “one embodiment” or “an embodiment” means that a particular feature, structure, or characteristic described in connection with the embodiment is included in at least one embodiment. Thus, appearances of the phrases “in one embodiment” or “in an embodiment” in various places throughout this specification are not necessarily all referring to the same embodiment. Furthermore, the particular features, structures, or characteristics may be combined in any suitable manner in one or more embodiments.
The terms and expressions which have been employed herein are used as terms of description and not of limitation, and there is no intention, in the use of such terms and expressions, of excluding any equivalents of the features shown and described (or portions thereof), and it is recognized that various modifications are possible within the scope of the claims. Accordingly, the claims are intended to cover all such equivalents.
References and citations to other documents, such as patents, patent applications, patent publications, journals, books, papers, web contents, have been made throughout this disclosure. All such documents are hereby incorporated herein by reference in their entirety for all purposes.
Various modifications and further embodiments are possible beyond what is shown and described herein. The subject matter herein contains information, exemplification, and guidance that can be adapted to create various other embodiments.
This application claims the benefit of, and priority to, U.S. Provisional Application No. 62/419,227, filed Nov. 8, 2016, the content of which is hereby incorporated by reference herein in its entirety.
Number | Name | Date | Kind |
---|---|---|---|
4699147 | Chilson et al. | Oct 1987 | A |
4976711 | Parins et al. | Dec 1990 | A |
4979948 | Geddes et al. | Dec 1990 | A |
5045056 | Behl | Sep 1991 | A |
5100423 | Fearnot | Mar 1992 | A |
5117828 | Metzger et al. | Jun 1992 | A |
5250074 | Wilk | Oct 1993 | A |
5334193 | Nardella | Aug 1994 | A |
5429605 | Richling et al. | Jul 1995 | A |
5471982 | Edwards et al. | Dec 1995 | A |
5472441 | Edwards et al. | Dec 1995 | A |
5486161 | Lax et al. | Jan 1996 | A |
5536267 | Edwards et al. | Jul 1996 | A |
5562720 | Stern et al. | Oct 1996 | A |
5657760 | Ying et al. | Aug 1997 | A |
5672153 | Lax et al. | Sep 1997 | A |
5672173 | Gough et al. | Sep 1997 | A |
5672174 | Gough et al. | Sep 1997 | A |
5683384 | Gough et al. | Nov 1997 | A |
5713942 | Stern et al. | Feb 1998 | A |
5728143 | Gough et al. | Mar 1998 | A |
5772590 | Webster, Jr. | Jun 1998 | A |
5782827 | Gough et al. | Jul 1998 | A |
5827276 | LeVeen et al. | Oct 1998 | A |
5840076 | Swanson et al. | Nov 1998 | A |
5846239 | Swanson et al. | Dec 1998 | A |
5855576 | LeVeen et al. | Jan 1999 | A |
5863290 | Gough et al. | Jan 1999 | A |
5868736 | Swanson et al. | Feb 1999 | A |
5868776 | Wright | Feb 1999 | A |
5871483 | Jackson et al. | Feb 1999 | A |
5888198 | Eggers et al. | Mar 1999 | A |
5891136 | McGee et al. | Apr 1999 | A |
5893847 | Kordis | Apr 1999 | A |
5913855 | Gough et al. | Jun 1999 | A |
5928229 | Gough et al. | Jul 1999 | A |
5935123 | Edwards et al. | Aug 1999 | A |
5961513 | Swanson et al. | Oct 1999 | A |
5980517 | Gough | Nov 1999 | A |
6009877 | Edwards | Jan 2000 | A |
6032077 | Pomeranz | Feb 2000 | A |
6036689 | Tu et al. | Mar 2000 | A |
6053913 | Tu et al. | Apr 2000 | A |
6053937 | Edwards et al. | Apr 2000 | A |
6063081 | Mulier et al. | May 2000 | A |
6071278 | Panescu et al. | Jun 2000 | A |
6071280 | Edwards et al. | Jun 2000 | A |
6099526 | Whayne et al. | Aug 2000 | A |
6112123 | Kelleher et al. | Aug 2000 | A |
6113598 | Baker | Sep 2000 | A |
6123718 | Tu et al. | Sep 2000 | A |
6142993 | Whayne et al. | Nov 2000 | A |
6221071 | Sherry et al. | Apr 2001 | B1 |
6241666 | Pomeranz et al. | Jun 2001 | B1 |
6251109 | Hassett et al. | Jun 2001 | B1 |
6258087 | Edwards et al. | Jul 2001 | B1 |
6309352 | Oraevsky et al. | Oct 2001 | B1 |
6312408 | Eggers et al. | Nov 2001 | B1 |
6312429 | Burbank et al. | Nov 2001 | B1 |
6358248 | Mulier et al. | Mar 2002 | B1 |
6379353 | Nichols | Apr 2002 | B1 |
6409722 | Hoey et al. | Jun 2002 | B1 |
6425877 | Edwards | Jul 2002 | B1 |
6454766 | Swanson et al. | Sep 2002 | B1 |
6491710 | Satake | Dec 2002 | B2 |
6494902 | Hoey et al. | Dec 2002 | B2 |
6503247 | Swartz et al. | Jan 2003 | B2 |
6522930 | Schaer et al. | Feb 2003 | B1 |
6537248 | Mulier et al. | Mar 2003 | B2 |
6537272 | Christopherson et al. | Mar 2003 | B2 |
6544262 | Fleischman | Apr 2003 | B2 |
6551310 | Ganz et al. | Apr 2003 | B1 |
6585732 | Mulier et al. | Jul 2003 | B2 |
6623481 | Garbagnati et al. | Sep 2003 | B1 |
6638275 | McGaffigan et al. | Oct 2003 | B1 |
6648883 | Francischelli et al. | Nov 2003 | B2 |
6663622 | Foley et al. | Dec 2003 | B1 |
6692466 | Chow et al. | Feb 2004 | B1 |
6736810 | Hoey et al. | May 2004 | B2 |
6736811 | Panescu et al. | May 2004 | B2 |
6743226 | Cosman et al. | Jun 2004 | B2 |
6764487 | Mulier et al. | Jul 2004 | B2 |
6770072 | Truckai | Aug 2004 | B1 |
6780183 | Jimenez, Jr. et al. | Aug 2004 | B2 |
6805131 | Kordis | Oct 2004 | B2 |
6826421 | Beatty et al. | Nov 2004 | B1 |
6849073 | Hoey et al. | Feb 2005 | B2 |
6872206 | Edwards et al. | Mar 2005 | B2 |
6878149 | Gatto | Apr 2005 | B2 |
6955641 | Lubock | Oct 2005 | B2 |
6978788 | Klimberg et al. | Dec 2005 | B2 |
6984232 | Vanney et al. | Jan 2006 | B2 |
7104989 | Skarda | Sep 2006 | B2 |
7150745 | Stern et al. | Dec 2006 | B2 |
7156845 | Mulier et al. | Jan 2007 | B2 |
7169144 | Hoey et al. | Jan 2007 | B2 |
7247155 | Hoey et al. | Jul 2007 | B2 |
7276061 | Schaer et al. | Oct 2007 | B2 |
7306593 | Keidar et al. | Dec 2007 | B2 |
7326208 | Vanney et al. | Feb 2008 | B2 |
7344535 | Stern et al. | Mar 2008 | B2 |
7364579 | Mulier et al. | Apr 2008 | B2 |
7367972 | Francischelli et al. | May 2008 | B2 |
7371231 | Rioux et al. | May 2008 | B2 |
7399299 | Daniel et al. | Jul 2008 | B2 |
7416552 | Paul et al. | Aug 2008 | B2 |
7419489 | Vanney et al. | Sep 2008 | B2 |
7556628 | Utley et al. | Jul 2009 | B2 |
7632268 | Edwards et al. | Dec 2009 | B2 |
7717909 | Strul et al. | May 2010 | B2 |
7769432 | Klimberg et al. | Aug 2010 | B2 |
7776034 | Kampa | Aug 2010 | B2 |
7803156 | Eder | Sep 2010 | B2 |
7828793 | Thompson et al. | Nov 2010 | B2 |
7862498 | Nguyen et al. | Jan 2011 | B2 |
7879030 | Paul et al. | Feb 2011 | B2 |
7942873 | Kwan et al. | May 2011 | B2 |
7959628 | Schaer et al. | Jun 2011 | B2 |
7959631 | DiCarlo | Jun 2011 | B2 |
8034022 | Boatman | Oct 2011 | B2 |
8043289 | Behl et al. | Oct 2011 | B2 |
8048069 | Skwarek et al. | Nov 2011 | B2 |
8114071 | Woloszko et al. | Feb 2012 | B2 |
8224416 | de la Rama et al. | Jul 2012 | B2 |
8303584 | Burdio Pinilla et al. | Nov 2012 | B2 |
8388573 | Cox | Mar 2013 | B1 |
8398624 | Rioux et al. | Mar 2013 | B2 |
8409193 | Young et al. | Apr 2013 | B2 |
8444638 | Woloszko et al. | May 2013 | B2 |
8465484 | Davalos et al. | Jun 2013 | B2 |
8465486 | Danek et al. | Jun 2013 | B2 |
8588886 | de la Rama et al. | Nov 2013 | B2 |
8591461 | Boatman | Nov 2013 | B2 |
8617158 | Garabedian et al. | Dec 2013 | B2 |
8647339 | Satake | Feb 2014 | B2 |
8657814 | Werneth et al. | Feb 2014 | B2 |
8734439 | Gough et al. | May 2014 | B2 |
8814855 | DiCarlo et al. | Aug 2014 | B2 |
8834461 | Werneth et al. | Sep 2014 | B2 |
8979841 | Kunis et al. | Mar 2015 | B2 |
9078665 | Moss et al. | Jul 2015 | B2 |
9131980 | Bloom | Sep 2015 | B2 |
9839472 | Rioux et al. | Dec 2017 | B2 |
9848936 | Rioux et al. | Dec 2017 | B2 |
9855098 | Rioux | Jan 2018 | B2 |
20010031941 | Edwards et al. | Oct 2001 | A1 |
20020026186 | Woloszko et al. | Feb 2002 | A1 |
20020062123 | McClurken et al. | May 2002 | A1 |
20020087208 | Koblish et al. | Jul 2002 | A1 |
20020095152 | Ciarrocca et al. | Jul 2002 | A1 |
20020115992 | Utley et al. | Aug 2002 | A1 |
20020120267 | Phan | Aug 2002 | A1 |
20030009166 | Moutafis et al. | Jan 2003 | A1 |
20030036680 | Black | Feb 2003 | A1 |
20030130711 | Pearson et al. | Jul 2003 | A1 |
20030158547 | Phan | Aug 2003 | A1 |
20030225403 | Woloszko et al. | Dec 2003 | A1 |
20040087936 | Stern et al. | May 2004 | A1 |
20040092960 | Abrams et al. | May 2004 | A1 |
20050154386 | West et al. | Jul 2005 | A1 |
20060212032 | Daniel et al. | Sep 2006 | A1 |
20060259027 | Kwan et al. | Nov 2006 | A1 |
20070083195 | Werneth et al. | Apr 2007 | A1 |
20080004534 | Gelbart et al. | Jan 2008 | A1 |
20080103494 | Rioux et al. | May 2008 | A1 |
20090171340 | Young | Jul 2009 | A1 |
20090248021 | McKenna | Oct 2009 | A1 |
20090292177 | Eggers et al. | Nov 2009 | A1 |
20090299355 | Bencini et al. | Dec 2009 | A1 |
20100114087 | Edwards et al. | May 2010 | A1 |
20100256629 | Wylie et al. | Oct 2010 | A1 |
20110172485 | Lubock | Jul 2011 | A1 |
20110257646 | Utley et al. | Oct 2011 | A1 |
20120029510 | Haverkost | Feb 2012 | A1 |
20120059437 | Shalev | Mar 2012 | A1 |
20120109250 | Cates et al. | May 2012 | A1 |
20120172680 | Gelfand et al. | Jul 2012 | A1 |
20130085493 | Bloom et al. | Apr 2013 | A1 |
20130158536 | Bloom | Jun 2013 | A1 |
20130172870 | Germain et al. | Jul 2013 | A1 |
20130184702 | Neal, II et al. | Jul 2013 | A1 |
20130253506 | Rioux et al. | Sep 2013 | A1 |
20140018788 | Engelman et al. | Jan 2014 | A1 |
20140018794 | Anderson et al. | Jan 2014 | A1 |
20140031810 | Mahvi et al. | Jan 2014 | A1 |
20140058376 | Horn et al. | Feb 2014 | A1 |
20140221998 | Latterell | Aug 2014 | A1 |
20140276731 | Voegele et al. | Sep 2014 | A1 |
20140276748 | Ku et al. | Sep 2014 | A1 |
20150018817 | Willard | Jan 2015 | A1 |
20150141982 | Lee | May 2015 | A1 |
20160113707 | Sahakian et al. | Apr 2016 | A1 |
20160113708 | Moss et al. | Apr 2016 | A1 |
20160184008 | Papaioannou et al. | Jun 2016 | A1 |
20160317221 | Rioux | Nov 2016 | A1 |
20170000559 | Rioux et al. | Jan 2017 | A1 |
20170027633 | Wham et al. | Feb 2017 | A1 |
20170119454 | Rioux et al. | May 2017 | A1 |
20170215947 | Rioux et al. | Aug 2017 | A1 |
20170215951 | Wang et al. | Aug 2017 | A1 |
20170252092 | Rioux et al. | Sep 2017 | A1 |
20170281267 | Rioux et al. | Oct 2017 | A1 |
20170281271 | Rioux | Oct 2017 | A1 |
20180014880 | Rioux et al. | Jan 2018 | A1 |
20180078305 | Rioux et al. | Mar 2018 | A1 |
20180104004 | Rioux et al. | Apr 2018 | A1 |
Number | Date | Country |
---|---|---|
2610858 | Apr 2004 | CN |
104546124 | Apr 2015 | CN |
102010032932 | Feb 2012 | DE |
0777445 | Jun 1999 | EP |
2942023 | Feb 2016 | EP |
3009735 | Feb 2000 | JP |
9510326 | Apr 1995 | WO |
9942047 | Aug 1999 | WO |
0051683 | Sep 2000 | WO |
2007-103986 | Sep 2007 | WO |
2012015722 | Feb 2012 | WO |
2014022379 | Feb 2014 | WO |
2014189887 | Nov 2014 | WO |
2015142674 | Sep 2015 | WO |
2015200518 | Dec 2015 | WO |
2016181318 | Nov 2016 | WO |
Entry |
---|
Non-Final Office Action dated May 7, 2018 for U.S. Appl. No. 15/142,616 (13 Pages). |
International Search Report and Written Opinion of the International Searching Authority dated Aug. 26, 2018 for International Application No. PCT/US2017/059850 (10 Pages). |
Notice of Allowance dated Jul. 24, 2018 for U.S. Appl. No. 15/784,778 (12 Pages). |
International Search Report and Written Opinion dated Jun. 6, 2018 for International Application No. PCT/US2018/019151 (17 Pages). |
International Search Report and Written Opinion of the International Searching Authority dated Sep. 16, 2018 or International Application No. PCT/US2018/036268 (11 Pages). |
International Search Report and Written Opinion of the Interational Searching Authority dated Feb. 27, 2018 for International Application No. PCT/US2017/056754 (11 Pages). |
International Search Report and Written Opinion of the International Searching Authority dated Nov. 1, 2018 for International Application No. PCT/US2018/043654 (10 Pages). |
International Search Report and Written Opinion of the International Searching Authority dated Nov. 15, 2018 for International Application PCT/US2018/043658 (15 Pages). |
“Aquamantys System” Product Brochure, Medtronic, 2014 (12 Pages). |
“Starburst Talon” Specifications Brochure, Angiodynamics, 2013 (2 Pages). |
Extended European Search Report dated Jun. 10, 2016 for European Application No. 13825361.2 (13 Pages). |
International Search Report and Written Opinion of the International Searching Authority dated Aug. 22, 2016 for International Application No. PCT/US2016/030081 (11 Pages). |
International Search Report and Written Opinion of the International Searching Authority dated Aug. 5, 2015 for International Application No. PCT/US2015/020596 (13 Pages). |
International Search Report and Written Opinion of the International Searching Authority dated Feb. 2, 2017 for International Application No. PCT/US2016/059345 (10 Pages). |
International Search Report and Written Opinion of the International Searching Authority dated Jun. 11, 2017 for ntemational Application No. PCT/US2017/019398 (27 Pages). |
International Search Report and Written Opinion of the International Searching Authority dated May 16, 2017 for International Application No. PCT/US2017/015582 (11 pages). |
International Search Report and Written Opinion of the International Searching Authority dated May 16, 2017 for International Application No. PCT/US2017/015584 (11 pages). |
International Search Report and Written Opinion of the International Searching Authority dated Nov. 29, 2013 or International Application No. PCT/US2013/052703 (11 Pages). |
International Search Report and Written Opinion of the International Searching Authority dated Oct. 19, 2017 for International Application No. PCT/US2017/041501 (63 Pages). |
Medtronic, “Aquamantys Bipolar Sealers.” Electrosurgical Products, Jun. 2017. Retrieved Jul. 21, 2017. <http://www.medtronic.com/us-en/healthcare-professionals/products/general-surgery/electrosurgical/aquamantys-bipolar-sealers.html> (11 Pages). |
Extended European Search Report, dated Feb. 28, 2020, Application No. 17895758.8, 8 pages. |
Number | Date | Country | |
---|---|---|---|
20180125570 A1 | May 2018 | US |
Number | Date | Country | |
---|---|---|---|
62419227 | Nov 2016 | US |